| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 1 Subunit | 106 | 2024 | 142 | 11.060 |
Why?
|
| Osteoblasts | 101 | 2024 | 205 | 10.110 |
Why?
|
| Osteogenesis | 52 | 2024 | 154 | 6.770 |
Why?
|
| Cell Differentiation | 106 | 2024 | 1386 | 6.380 |
Why?
|
| Epigenesis, Genetic | 48 | 2025 | 407 | 4.930 |
Why?
|
| MicroRNAs | 32 | 2024 | 710 | 4.600 |
Why?
|
| Transcription Factors | 90 | 2024 | 1554 | 4.250 |
Why?
|
| Bone Neoplasms | 23 | 2016 | 121 | 3.690 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 34 | 2023 | 82 | 3.620 |
Why?
|
| Gene Expression Regulation, Neoplastic | 44 | 2025 | 583 | 2.930 |
Why?
|
| RNA, Long Noncoding | 9 | 2025 | 171 | 2.910 |
Why?
|
| Gene Expression Regulation | 68 | 2025 | 1630 | 2.780 |
Why?
|
| Breast Neoplasms | 30 | 2023 | 1222 | 2.750 |
Why?
|
| Bone and Bones | 24 | 2017 | 152 | 2.650 |
Why?
|
| Gene Expression Regulation, Developmental | 36 | 2020 | 663 | 2.550 |
Why?
|
| Transcription, Genetic | 53 | 2019 | 907 | 2.460 |
Why?
|
| Promoter Regions, Genetic | 60 | 2020 | 687 | 2.460 |
Why?
|
| Prostatic Neoplasms | 14 | 2024 | 493 | 2.440 |
Why?
|
| Histones | 48 | 2025 | 494 | 2.400 |
Why?
|
| Animals | 227 | 2025 | 21324 | 2.210 |
Why?
|
| Cell Proliferation | 53 | 2024 | 1036 | 2.150 |
Why?
|
| Mice | 141 | 2024 | 11105 | 2.020 |
Why?
|
| Chondrocytes | 15 | 2021 | 45 | 1.920 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2024 | 71 | 1.910 |
Why?
|
| Cell Nucleus | 56 | 2018 | 630 | 1.910 |
Why?
|
| Homeodomain Proteins | 14 | 2015 | 277 | 1.890 |
Why?
|
| Signal Transduction | 48 | 2023 | 3149 | 1.820 |
Why?
|
| Chromatin Assembly and Disassembly | 16 | 2018 | 236 | 1.820 |
Why?
|
| Cell Line, Tumor | 60 | 2024 | 1566 | 1.810 |
Why?
|
| Bone Development | 13 | 2015 | 33 | 1.800 |
Why?
|
| Mitosis | 24 | 2025 | 222 | 1.760 |
Why?
|
| Transforming Growth Factor beta | 14 | 2010 | 181 | 1.740 |
Why?
|
| Neoplasm Proteins | 28 | 2015 | 285 | 1.720 |
Why?
|
| Bone Morphogenetic Proteins | 13 | 2016 | 64 | 1.720 |
Why?
|
| DNA-Binding Proteins | 36 | 2022 | 1225 | 1.670 |
Why?
|
| Chromatin | 36 | 2025 | 641 | 1.640 |
Why?
|
| Cell Lineage | 25 | 2022 | 282 | 1.580 |
Why?
|
| Osteocalcin | 28 | 2018 | 46 | 1.550 |
Why?
|
| Biomarkers, Tumor | 6 | 2024 | 524 | 1.510 |
Why?
|
| Neoplasms | 20 | 2025 | 1367 | 1.470 |
Why?
|
| Nuclear Proteins | 29 | 2024 | 790 | 1.450 |
Why?
|
| Up-Regulation | 17 | 2018 | 374 | 1.240 |
Why?
|
| Cell Cycle | 31 | 2023 | 398 | 1.240 |
Why?
|
| Gene Regulatory Networks | 7 | 2016 | 160 | 1.210 |
Why?
|
| Humans | 202 | 2025 | 65124 | 1.160 |
Why?
|
| Smad Proteins | 5 | 2015 | 23 | 1.160 |
Why?
|
| Transcriptional Activation | 25 | 2020 | 197 | 1.140 |
Why?
|
| Embryonic Stem Cells | 14 | 2017 | 154 | 1.110 |
Why?
|
| Cell Line | 50 | 2019 | 2023 | 1.100 |
Why?
|
| Calcification, Physiologic | 9 | 2019 | 20 | 1.090 |
Why?
|
| Repressor Proteins | 21 | 2019 | 351 | 1.070 |
Why?
|
| Osteosarcoma | 17 | 2020 | 48 | 1.050 |
Why?
|
| Receptors, Calcitriol | 16 | 2019 | 33 | 0.990 |
Why?
|
| Gene Expression Profiling | 25 | 2018 | 794 | 0.980 |
Why?
|
| Genome | 5 | 2017 | 285 | 0.960 |
Why?
|
| Fracture Healing | 4 | 2014 | 26 | 0.950 |
Why?
|
| Down-Regulation | 15 | 2018 | 324 | 0.910 |
Why?
|
| Cell Movement | 11 | 2017 | 480 | 0.900 |
Why?
|
| Homeostasis | 6 | 2023 | 378 | 0.890 |
Why?
|
| Rats | 41 | 2021 | 1994 | 0.870 |
Why?
|
| Bone Diseases | 2 | 2014 | 25 | 0.850 |
Why?
|
| Bone Morphogenetic Protein 2 | 14 | 2018 | 49 | 0.850 |
Why?
|
| Stem Cells | 12 | 2014 | 276 | 0.820 |
Why?
|
| Osteolysis | 4 | 2014 | 19 | 0.820 |
Why?
|
| Phenotype | 29 | 2022 | 1232 | 0.810 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 9 | 2012 | 156 | 0.790 |
Why?
|
| DNA Helicases | 8 | 2018 | 198 | 0.740 |
Why?
|
| Wnt Signaling Pathway | 4 | 2019 | 86 | 0.700 |
Why?
|
| Cells, Cultured | 36 | 2024 | 2188 | 0.680 |
Why?
|
| Mesoderm | 12 | 2016 | 89 | 0.670 |
Why?
|
| Cell Cycle Proteins | 18 | 2024 | 402 | 0.660 |
Why?
|
| DNA | 18 | 2017 | 858 | 0.660 |
Why?
|
| Osteoclasts | 9 | 2024 | 53 | 0.650 |
Why?
|
| Wnt Proteins | 8 | 2013 | 104 | 0.630 |
Why?
|
| Core Binding Factor beta Subunit | 10 | 2023 | 22 | 0.630 |
Why?
|
| Bone Remodeling | 7 | 2015 | 25 | 0.620 |
Why?
|
| Deoxyribonucleases | 2 | 2017 | 32 | 0.600 |
Why?
|
| Protein Binding | 30 | 2019 | 1639 | 0.600 |
Why?
|
| Fractures, Bone | 3 | 2011 | 138 | 0.590 |
Why?
|
| Cissus | 4 | 2020 | 4 | 0.580 |
Why?
|
| Chondrogenesis | 6 | 2021 | 11 | 0.570 |
Why?
|
| Embryo, Mammalian | 11 | 2013 | 158 | 0.570 |
Why?
|
| CCCTC-Binding Factor | 2 | 2017 | 41 | 0.570 |
Why?
|
| Mice, Knockout | 24 | 2021 | 2155 | 0.570 |
Why?
|
| RNA Interference | 18 | 2017 | 643 | 0.570 |
Why?
|
| Gene Expression | 14 | 2019 | 852 | 0.560 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2023 | 61 | 0.560 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2014 | 182 | 0.540 |
Why?
|
| Membrane Proteins | 5 | 2016 | 918 | 0.540 |
Why?
|
| Models, Biological | 20 | 2017 | 1192 | 0.530 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2005 | 343 | 0.530 |
Why?
|
| Mice, Transgenic | 18 | 2016 | 1287 | 0.530 |
Why?
|
| Titanium | 3 | 2024 | 59 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 730 | 0.520 |
Why?
|
| Carcinogenesis | 6 | 2018 | 134 | 0.520 |
Why?
|
| Oncogene Proteins, Fusion | 8 | 2017 | 64 | 0.520 |
Why?
|
| RNA, Untranslated | 5 | 2015 | 105 | 0.510 |
Why?
|
| RNA, Messenger | 26 | 2020 | 1575 | 0.510 |
Why?
|
| Human Embryonic Stem Cells | 5 | 2017 | 38 | 0.510 |
Why?
|
| Plant Extracts | 4 | 2020 | 130 | 0.510 |
Why?
|
| Oxidoreductases | 6 | 2016 | 58 | 0.500 |
Why?
|
| Multigene Family | 3 | 2023 | 106 | 0.490 |
Why?
|
| Multiprotein Complexes | 6 | 2015 | 156 | 0.490 |
Why?
|
| Disease Progression | 13 | 2018 | 1219 | 0.490 |
Why?
|
| Base Sequence | 23 | 2014 | 1329 | 0.490 |
Why?
|
| Trans-Activators | 9 | 2007 | 321 | 0.480 |
Why?
|
| Nuclear Matrix | 13 | 2017 | 28 | 0.480 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 55 | 0.480 |
Why?
|
| Adenocarcinoma | 4 | 2016 | 366 | 0.470 |
Why?
|
| Female | 52 | 2023 | 34016 | 0.470 |
Why?
|
| Genome, Human | 5 | 2018 | 237 | 0.470 |
Why?
|
| Proteins | 9 | 2008 | 764 | 0.470 |
Why?
|
| Interleukin-11 | 1 | 2015 | 8 | 0.460 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 15 | 0.460 |
Why?
|
| Fibroblasts | 8 | 2016 | 422 | 0.460 |
Why?
|
| Bone Resorption | 4 | 2015 | 46 | 0.460 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2020 | 84 | 0.450 |
Why?
|
| Pluripotent Stem Cells | 7 | 2015 | 72 | 0.440 |
Why?
|
| Core Binding Factor alpha Subunits | 15 | 2018 | 20 | 0.430 |
Why?
|
| Hydroxamic Acids | 3 | 2011 | 29 | 0.420 |
Why?
|
| Cartilage | 5 | 2014 | 35 | 0.420 |
Why?
|
| Vitamin D | 9 | 2010 | 139 | 0.420 |
Why?
|
| HeLa Cells | 18 | 2014 | 541 | 0.420 |
Why?
|
| 3T3 Cells | 12 | 2019 | 111 | 0.410 |
Why?
|
| Biomarkers | 9 | 2014 | 1480 | 0.410 |
Why?
|
| Mice, SCID | 8 | 2020 | 518 | 0.410 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2016 | 131 | 0.400 |
Why?
|
| DNA Methylation | 11 | 2025 | 302 | 0.400 |
Why?
|
| RNA, Neoplasm | 2 | 2012 | 36 | 0.400 |
Why?
|
| Neoplasm Metastasis | 8 | 2012 | 222 | 0.400 |
Why?
|
| Boronic Acids | 2 | 2010 | 28 | 0.390 |
Why?
|
| Pyrazines | 2 | 2010 | 35 | 0.390 |
Why?
|
| Leukotriene Antagonists | 2 | 2010 | 8 | 0.390 |
Why?
|
| G1 Phase | 9 | 2018 | 58 | 0.390 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2020 | 210 | 0.390 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2010 | 129 | 0.390 |
Why?
|
| Microscopy, Fluorescence | 15 | 2013 | 401 | 0.380 |
Why?
|
| Blotting, Western | 15 | 2017 | 610 | 0.380 |
Why?
|
| Hedgehog Proteins | 3 | 2008 | 116 | 0.370 |
Why?
|
| Embryonic Development | 2 | 2016 | 142 | 0.370 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 29 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2014 | 542 | 0.370 |
Why?
|
| Protease Inhibitors | 2 | 2010 | 106 | 0.370 |
Why?
|
| Binding Sites | 15 | 2015 | 921 | 0.360 |
Why?
|
| Cartilage, Articular | 3 | 2023 | 79 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2017 | 205 | 0.360 |
Why?
|
| Chromatin Immunoprecipitation | 11 | 2017 | 146 | 0.360 |
Why?
|
| Male | 37 | 2024 | 31042 | 0.350 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 318 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 19 | 2022 | 3478 | 0.350 |
Why?
|
| Models, Genetic | 11 | 2012 | 266 | 0.340 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2010 | 38 | 0.340 |
Why?
|
| Cell Survival | 4 | 2024 | 587 | 0.340 |
Why?
|
| MCF-7 Cells | 5 | 2018 | 65 | 0.340 |
Why?
|
| RNA | 5 | 2020 | 426 | 0.340 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2010 | 3 | 0.330 |
Why?
|
| RNA, Ribosomal | 6 | 2016 | 60 | 0.330 |
Why?
|
| Leukotrienes | 1 | 2010 | 4 | 0.330 |
Why?
|
| Arachidonic Acid | 1 | 2010 | 38 | 0.330 |
Why?
|
| Eicosanoids | 1 | 2010 | 25 | 0.320 |
Why?
|
| Neoplastic Stem Cells | 4 | 2020 | 195 | 0.320 |
Why?
|
| Transfection | 16 | 2017 | 701 | 0.320 |
Why?
|
| Vitamin D3 24-Hydroxylase | 2 | 2020 | 7 | 0.310 |
Why?
|
| Receptors, Leukotriene | 1 | 2009 | 2 | 0.310 |
Why?
|
| Mutation | 17 | 2022 | 2658 | 0.310 |
Why?
|
| Molecular Sequence Data | 14 | 2014 | 1979 | 0.310 |
Why?
|
| Endoribonucleases | 1 | 2010 | 57 | 0.310 |
Why?
|
| Genomics | 4 | 2018 | 384 | 0.300 |
Why?
|
| Phosphoproteins | 3 | 2012 | 224 | 0.300 |
Why?
|
| DNA Damage | 7 | 2015 | 298 | 0.300 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2007 | 103 | 0.300 |
Why?
|
| Tibial Fractures | 1 | 2009 | 13 | 0.300 |
Why?
|
| Epithelial Cells | 6 | 2020 | 410 | 0.300 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 179 | 0.300 |
Why?
|
| RNA, Small Interfering | 12 | 2016 | 980 | 0.300 |
Why?
|
| Nucleosomes | 8 | 2025 | 190 | 0.290 |
Why?
|
| Tibia | 1 | 2009 | 75 | 0.290 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2008 | 6 | 0.290 |
Why?
|
| Genes, Switch | 1 | 2008 | 6 | 0.290 |
Why?
|
| Translocation, Genetic | 7 | 2017 | 74 | 0.280 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2025 | 268 | 0.280 |
Why?
|
| DNA Replication | 5 | 2016 | 247 | 0.280 |
Why?
|
| Amino Acids | 2 | 2008 | 148 | 0.280 |
Why?
|
| Genomic Instability | 4 | 2018 | 59 | 0.280 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2022 | 20 | 0.270 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 168 | 0.270 |
Why?
|
| Cleidocranial Dysplasia | 5 | 2014 | 8 | 0.270 |
Why?
|
| Skull | 5 | 2014 | 52 | 0.270 |
Why?
|
| Thyroid Hormone Receptors beta | 2 | 2018 | 5 | 0.260 |
Why?
|
| Tumor Cells, Cultured | 12 | 2010 | 426 | 0.260 |
Why?
|
| Cholecalciferol | 5 | 2020 | 28 | 0.260 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2014 | 22 | 0.260 |
Why?
|
| Inflammation | 2 | 2012 | 1187 | 0.260 |
Why?
|
| Bone Marrow Cells | 6 | 2014 | 237 | 0.260 |
Why?
|
| Kidney | 2 | 2008 | 451 | 0.250 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2014 | 65 | 0.250 |
Why?
|
| Tumor Microenvironment | 5 | 2020 | 182 | 0.250 |
Why?
|
| Protein Transport | 14 | 2012 | 405 | 0.250 |
Why?
|
| 3' Untranslated Regions | 5 | 2016 | 95 | 0.250 |
Why?
|
| Sialoglycoproteins | 5 | 2012 | 20 | 0.240 |
Why?
|
| DNA Repair | 3 | 2016 | 262 | 0.240 |
Why?
|
| Acetylation | 10 | 2025 | 121 | 0.240 |
Why?
|
| Hematopoiesis | 4 | 2013 | 127 | 0.240 |
Why?
|
| Computational Biology | 6 | 2017 | 367 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 21 | 6 | 2017 | 30 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 8 | 6 | 2017 | 33 | 0.240 |
Why?
|
| RANK Ligand | 4 | 2016 | 23 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 287 | 0.230 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 6 | 2017 | 11 | 0.230 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2015 | 19 | 0.230 |
Why?
|
| Lysine | 2 | 2016 | 94 | 0.230 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2016 | 47 | 0.230 |
Why?
|
| Intranuclear Space | 3 | 2010 | 5 | 0.230 |
Why?
|
| Chromosomes | 5 | 2016 | 139 | 0.230 |
Why?
|
| Gene Knockdown Techniques | 6 | 2017 | 203 | 0.220 |
Why?
|
| Alkaline Phosphatase | 6 | 2019 | 46 | 0.220 |
Why?
|
| Animals, Newborn | 3 | 2008 | 241 | 0.220 |
Why?
|
| Parathyroid Hormone-Related Protein | 3 | 2016 | 9 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2011 | 297 | 0.220 |
Why?
|
| Apoptosis | 8 | 2017 | 1100 | 0.210 |
Why?
|
| Time Factors | 14 | 2014 | 3762 | 0.210 |
Why?
|
| Amino Acid Sequence | 8 | 2009 | 1589 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2015 | 191 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 13 | 2010 | 676 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 345 | 0.210 |
Why?
|
| Axin Protein | 2 | 2014 | 10 | 0.200 |
Why?
|
| Cell Self Renewal | 1 | 2023 | 13 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 4 | 2017 | 256 | 0.200 |
Why?
|
| Osteopontin | 5 | 2019 | 21 | 0.200 |
Why?
|
| Radiography | 3 | 2010 | 555 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 204 | 0.200 |
Why?
|
| Bone Density | 5 | 2022 | 142 | 0.200 |
Why?
|
| Brain | 3 | 2008 | 1604 | 0.200 |
Why?
|
| Point Mutation | 5 | 2013 | 168 | 0.200 |
Why?
|
| Ribonuclease III | 2 | 2016 | 87 | 0.190 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2005 | 14 | 0.190 |
Why?
|
| Hypertrophy | 3 | 2009 | 29 | 0.190 |
Why?
|
| Interphase | 5 | 2016 | 68 | 0.190 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 6 | 0.190 |
Why?
|
| Calcitriol | 4 | 2010 | 25 | 0.190 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2022 | 22 | 0.190 |
Why?
|
| Neural Crest | 2 | 2013 | 30 | 0.190 |
Why?
|
| Anaphase | 1 | 2022 | 35 | 0.180 |
Why?
|
| Cell Division | 7 | 2022 | 449 | 0.180 |
Why?
|
| Chromosome Segregation | 1 | 2022 | 43 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 440 | 0.180 |
Why?
|
| Gene Deletion | 5 | 2012 | 312 | 0.180 |
Why?
|
| Vitamin D Response Element | 5 | 2004 | 6 | 0.180 |
Why?
|
| Bone Regeneration | 3 | 2012 | 14 | 0.180 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 28 | 0.180 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2013 | 78 | 0.180 |
Why?
|
| Prognosis | 2 | 2024 | 1785 | 0.170 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2021 | 2 | 0.170 |
Why?
|
| Nanostructures | 2 | 2024 | 188 | 0.170 |
Why?
|
| Osteoarthritis | 1 | 2023 | 146 | 0.170 |
Why?
|
| Pre-B-Cell Leukemia Transcription Factor 1 | 2 | 2011 | 4 | 0.170 |
Why?
|
| DNA Primers | 8 | 2010 | 301 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2017 | 17 | 0.170 |
Why?
|
| Response Elements | 3 | 2016 | 44 | 0.160 |
Why?
|
| Protein Isoforms | 7 | 2015 | 202 | 0.160 |
Why?
|
| Minerals | 2 | 2011 | 20 | 0.160 |
Why?
|
| Genes, Reporter | 8 | 2016 | 257 | 0.160 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2011 | 63 | 0.160 |
Why?
|
| Cyclin E | 3 | 2023 | 14 | 0.160 |
Why?
|
| Phosphorylation | 9 | 2016 | 962 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2017 | 51 | 0.160 |
Why?
|
| Genetic Markers | 2 | 2017 | 129 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2020 | 17 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2010 | 203 | 0.160 |
Why?
|
| NIH 3T3 Cells | 6 | 2012 | 99 | 0.160 |
Why?
|
| Mitochondria | 4 | 2011 | 409 | 0.160 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2019 | 27 | 0.150 |
Why?
|
| Cellular Senescence | 3 | 2011 | 120 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2011 | 50 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2013 | 251 | 0.150 |
Why?
|
| Adiponectin | 2 | 2020 | 37 | 0.150 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 86 | 0.150 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 4 | 2009 | 4 | 0.150 |
Why?
|
| HEK293 Cells | 4 | 2018 | 615 | 0.150 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2019 | 35 | 0.150 |
Why?
|
| Transcription Factor AP-2 | 8 | 2005 | 11 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 704 | 0.150 |
Why?
|
| S Phase | 5 | 2018 | 79 | 0.150 |
Why?
|
| Integrin beta3 | 1 | 2019 | 8 | 0.150 |
Why?
|
| Leukemia, Myeloid | 3 | 2017 | 35 | 0.150 |
Why?
|
| Thyroid Neoplasms | 2 | 2018 | 87 | 0.150 |
Why?
|
| Introns | 2 | 2017 | 111 | 0.150 |
Why?
|
| Adipogenesis | 1 | 2020 | 81 | 0.140 |
Why?
|
| Chromosomes, Human | 2 | 2011 | 52 | 0.140 |
Why?
|
| RNA, Transfer | 1 | 2020 | 93 | 0.140 |
Why?
|
| Co-Repressor Proteins | 3 | 2017 | 22 | 0.140 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 8 | 0.140 |
Why?
|
| Gene Silencing | 2 | 2012 | 430 | 0.140 |
Why?
|
| Histone Acetyltransferases | 3 | 2008 | 59 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 28 | 0.140 |
Why?
|
| Genes, rRNA | 2 | 2008 | 9 | 0.140 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 24 | 0.140 |
Why?
|
| Fractures, Spontaneous | 1 | 2017 | 6 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 12 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2017 | 38 | 0.130 |
Why?
|
| Osteochondrodysplasias | 1 | 2017 | 12 | 0.130 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2009 | 12 | 0.130 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2017 | 8 | 0.130 |
Why?
|
| G2 Phase | 2 | 2016 | 23 | 0.130 |
Why?
|
| Oncogenes | 2 | 2017 | 70 | 0.130 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2017 | 3 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 6 | 2010 | 61 | 0.130 |
Why?
|
| RNA, Small Untranslated | 1 | 2017 | 19 | 0.130 |
Why?
|
| Microscopy | 2 | 2016 | 99 | 0.130 |
Why?
|
| Nucleolus Organizer Region | 4 | 2010 | 7 | 0.130 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2015 | 40 | 0.130 |
Why?
|
| WW Domain-Containing Oxidoreductase | 6 | 2016 | 6 | 0.130 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 2 | 2007 | 10 | 0.130 |
Why?
|
| Matrix Attachment Regions | 1 | 2017 | 4 | 0.130 |
Why?
|
| DNA Topoisomerases | 1 | 2017 | 4 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2014 | 72 | 0.130 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cell Growth Processes | 3 | 2012 | 36 | 0.130 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 3 | 2012 | 8 | 0.130 |
Why?
|
| RNA, Messenger, Stored | 1 | 2016 | 5 | 0.120 |
Why?
|
| Synovial Membrane | 1 | 2016 | 21 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2024 | 2102 | 0.120 |
Why?
|
| Aggression | 1 | 2017 | 79 | 0.120 |
Why?
|
| Serotonin | 1 | 2017 | 62 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 180 | 0.120 |
Why?
|
| Zygote | 1 | 2016 | 45 | 0.120 |
Why?
|
| Ribonucleoproteins | 2 | 2010 | 116 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 509 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2009 | 710 | 0.120 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 237 | 0.120 |
Why?
|
| Estrogens | 2 | 2022 | 115 | 0.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2015 | 7 | 0.120 |
Why?
|
| Dronabinol | 2 | 2008 | 31 | 0.120 |
Why?
|
| Collagen Type X | 2 | 2006 | 4 | 0.120 |
Why?
|
| Leukemia | 2 | 2014 | 62 | 0.120 |
Why?
|
| Collagen Type II | 2 | 2006 | 12 | 0.120 |
Why?
|
| Periodontitis | 1 | 2015 | 15 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 34 | 0.120 |
Why?
|
| Osteocytes | 2 | 2005 | 14 | 0.120 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 43 | 0.110 |
Why?
|
| Collagen Type I | 2 | 2019 | 44 | 0.110 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2015 | 2 | 0.110 |
Why?
|
| Stromal Cells | 3 | 2011 | 78 | 0.110 |
Why?
|
| Telomere | 1 | 2015 | 58 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2011 | 500 | 0.110 |
Why?
|
| Cell Culture Techniques | 4 | 2010 | 195 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 644 | 0.110 |
Why?
|
| Acetates | 2 | 2018 | 30 | 0.110 |
Why?
|
| Prostate | 1 | 2016 | 122 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2018 | 19 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 513 | 0.110 |
Why?
|
| Cytoplasmic Structures | 1 | 2014 | 1 | 0.110 |
Why?
|
| Protein Subunits | 2 | 2006 | 169 | 0.110 |
Why?
|
| Epigenomics | 2 | 2018 | 62 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2014 | 48 | 0.110 |
Why?
|
| Histone Code | 3 | 2020 | 25 | 0.110 |
Why?
|
| Mutant Proteins | 3 | 2010 | 105 | 0.110 |
Why?
|
| Cytokinesis | 1 | 2014 | 41 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 7 | 2010 | 115 | 0.110 |
Why?
|
| Integrin-Binding Sialoprotein | 3 | 2010 | 5 | 0.110 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 301 | 0.110 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 896 | 0.100 |
Why?
|
| Nuclear Localization Signals | 3 | 2009 | 20 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 62 | 0.100 |
Why?
|
| Reference Standards | 1 | 2014 | 76 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2017 | 233 | 0.100 |
Why?
|
| Eukaryota | 1 | 2014 | 31 | 0.100 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2013 | 21 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 29 | 0.100 |
Why?
|
| Mammary Glands, Human | 2 | 2015 | 56 | 0.100 |
Why?
|
| Sp7 Transcription Factor | 2 | 2011 | 4 | 0.100 |
Why?
|
| Macrophages | 3 | 2015 | 1037 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2011 | 293 | 0.100 |
Why?
|
| Genes, Lethal | 3 | 2010 | 57 | 0.100 |
Why?
|
| Feedback, Physiological | 2 | 2010 | 59 | 0.100 |
Why?
|
| Integrins | 1 | 2014 | 109 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2013 | 58 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 47 | 0.100 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2013 | 11 | 0.100 |
Why?
|
| Facial Bones | 1 | 2013 | 10 | 0.100 |
Why?
|
| Bortezomib | 2 | 2010 | 59 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 136 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2013 | 11 | 0.100 |
Why?
|
| Wound Healing | 1 | 2014 | 193 | 0.100 |
Why?
|
| Ethanol | 1 | 2016 | 330 | 0.100 |
Why?
|
| Cyclin D2 | 2 | 2010 | 8 | 0.100 |
Why?
|
| Steroids | 2 | 2013 | 55 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 178 | 0.090 |
Why?
|
| X-Ray Microtomography | 3 | 2022 | 27 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 354 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2010 | 18 | 0.090 |
Why?
|
| Epitopes | 2 | 2004 | 291 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2016 | 346 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 2 | 2016 | 38 | 0.090 |
Why?
|
| Hydroxyurea | 2 | 2009 | 19 | 0.090 |
Why?
|
| Growth Differentiation Factor 10 | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cell Line, Transformed | 3 | 2008 | 97 | 0.090 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2009 | 21 | 0.090 |
Why?
|
| Ribosomes | 1 | 2014 | 170 | 0.090 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 4 | 0.090 |
Why?
|
| Surface Properties | 2 | 2024 | 283 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 30 | 0.090 |
Why?
|
| Dentin | 1 | 2012 | 5 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2013 | 113 | 0.090 |
Why?
|
| Cyclins | 4 | 2007 | 41 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 215 | 0.090 |
Why?
|
| Vitamin K | 1 | 2012 | 15 | 0.090 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 19 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2015 | 718 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 38 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2018 | 544 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2008 | 85 | 0.090 |
Why?
|
| Health | 1 | 2011 | 30 | 0.090 |
Why?
|
| Bone Diseases, Developmental | 1 | 2011 | 7 | 0.090 |
Why?
|
| Societies, Scientific | 1 | 2011 | 36 | 0.090 |
Why?
|
| Obesity | 1 | 2020 | 1273 | 0.090 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2011 | 1 | 0.090 |
Why?
|
| Transcriptome | 3 | 2022 | 399 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2012 | 189 | 0.090 |
Why?
|
| Cytoplasm | 3 | 2010 | 283 | 0.080 |
Why?
|
| Quinones | 1 | 2010 | 5 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 100 | 0.080 |
Why?
|
| Amino Acid Motifs | 5 | 2010 | 156 | 0.080 |
Why?
|
| Lactams | 1 | 2010 | 21 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2010 | 75 | 0.080 |
Why?
|
| Metaphase | 3 | 2022 | 36 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2008 | 152 | 0.080 |
Why?
|
| Plasmids | 2 | 2009 | 294 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 15 | 0.080 |
Why?
|
| Growth Plate | 2 | 2008 | 14 | 0.080 |
Why?
|
| Aromatase | 1 | 2010 | 5 | 0.080 |
Why?
|
| Risk Factors | 2 | 2019 | 5429 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 102 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2017 | 299 | 0.080 |
Why?
|
| Extremities | 1 | 2010 | 63 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2010 | 33 | 0.080 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2009 | 9 | 0.080 |
Why?
|
| Leukotriene B4 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 148 | 0.080 |
Why?
|
| Androgens | 1 | 2010 | 66 | 0.080 |
Why?
|
| Granulocytes | 2 | 2009 | 73 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2010 | 145 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 185 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Tetracycline | 1 | 2009 | 22 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 196 | 0.080 |
Why?
|
| Sulfides | 1 | 2009 | 22 | 0.080 |
Why?
|
| Bone Substitutes | 1 | 2009 | 16 | 0.080 |
Why?
|
| Bony Callus | 1 | 2009 | 3 | 0.080 |
Why?
|
| RNA 3' End Processing | 1 | 2009 | 5 | 0.080 |
Why?
|
| Kinetics | 4 | 2016 | 759 | 0.080 |
Why?
|
| Elastomers | 1 | 2009 | 7 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 2 | 2006 | 13 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 160 | 0.080 |
Why?
|
| Quinolines | 1 | 2009 | 47 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 396 | 0.080 |
Why?
|
| Deoxyribonuclease I | 2 | 2013 | 41 | 0.080 |
Why?
|
| High Mobility Group Proteins | 2 | 2006 | 27 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2009 | 55 | 0.080 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2009 | 4 | 0.070 |
Why?
|
| Sterols | 1 | 2009 | 6 | 0.070 |
Why?
|
| Durapatite | 1 | 2009 | 27 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2009 | 34 | 0.070 |
Why?
|
| Chromosome Breakage | 1 | 2009 | 6 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 232 | 0.070 |
Why?
|
| Embryonic and Fetal Development | 3 | 2003 | 46 | 0.070 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2009 | 36 | 0.070 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2009 | 110 | 0.070 |
Why?
|
| Genes, bcl-1 | 1 | 2008 | 2 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 21 | 0.070 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2008 | 2 | 0.070 |
Why?
|
| Mammals | 1 | 2010 | 222 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 54 | 0.070 |
Why?
|
| Twist-Related Protein 1 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2009 | 77 | 0.070 |
Why?
|
| Adult | 3 | 2015 | 17356 | 0.070 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2008 | 26 | 0.070 |
Why?
|
| Parathyroid Glands | 1 | 2008 | 9 | 0.070 |
Why?
|
| Carcinoma | 2 | 2007 | 130 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2011 | 262 | 0.070 |
Why?
|
| Ectodermal Dysplasia | 1 | 2008 | 6 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 213 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 44 | 0.070 |
Why?
|
| Frameshift Mutation | 1 | 2008 | 29 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 90 | 0.070 |
Why?
|
| Organ Size | 3 | 2015 | 173 | 0.070 |
Why?
|
| Histone Deacetylases | 2 | 2013 | 67 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 240 | 0.070 |
Why?
|
| Blastocyst | 3 | 2016 | 74 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 198 | 0.070 |
Why?
|
| Cannabinoids | 1 | 2008 | 41 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2002 | 55 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Skeleton | 2 | 2006 | 3 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Protein Stability | 2 | 2021 | 96 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 32 | 0.060 |
Why?
|
| Cyclin B | 1 | 2007 | 17 | 0.060 |
Why?
|
| Phosphoserine | 1 | 2007 | 10 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 137 | 0.060 |
Why?
|
| Luciferases | 3 | 2014 | 107 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2007 | 16 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2004 | 77 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 76 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 42 | 0.060 |
Why?
|
| Genes, cdc | 1 | 2007 | 15 | 0.060 |
Why?
|
| Cell Communication | 2 | 2004 | 133 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 55 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2007 | 64 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 247 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2017 | 90 | 0.060 |
Why?
|
| Protein Sorting Signals | 2 | 2006 | 55 | 0.060 |
Why?
|
| Organ Specificity | 3 | 2017 | 198 | 0.060 |
Why?
|
| Proteolysis | 2 | 2021 | 154 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2284 | 0.060 |
Why?
|
| Smad5 Protein | 2 | 2005 | 7 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2008 | 267 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2008 | 173 | 0.060 |
Why?
|
| RNA Splice Sites | 1 | 2006 | 22 | 0.060 |
Why?
|
| Caspase 3 | 3 | 2016 | 108 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 33 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2021 | 117 | 0.060 |
Why?
|
| beta Catenin | 1 | 2006 | 99 | 0.060 |
Why?
|
| RNA Polymerase II | 3 | 2011 | 86 | 0.060 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2005 | 11 | 0.060 |
Why?
|
| Cell Nucleolus | 3 | 2012 | 71 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2016 | 417 | 0.060 |
Why?
|
| Fluorescence Recovery After Photobleaching | 3 | 2011 | 23 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2005 | 12 | 0.060 |
Why?
|
| Tubulin | 1 | 2006 | 73 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 771 | 0.060 |
Why?
|
| Mediator Complex Subunit 1 | 3 | 2010 | 7 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 165 | 0.060 |
Why?
|
| DNA, Ribosomal | 3 | 2012 | 31 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2011 | 161 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2006 | 98 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2005 | 130 | 0.060 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 128 | 0.050 |
Why?
|
| Microtubules | 1 | 2006 | 210 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2024 | 104 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 2 | 2021 | 368 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 59 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 1006 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 856 | 0.050 |
Why?
|
| Procollagen | 2 | 2016 | 11 | 0.050 |
Why?
|
| Uridine Triphosphate | 1 | 2004 | 2 | 0.050 |
Why?
|
| Cell Fractionation | 4 | 2005 | 32 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 20 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2003 | 18 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 300 | 0.050 |
Why?
|
| Lasers | 1 | 2003 | 37 | 0.050 |
Why?
|
| Biochemistry | 1 | 2004 | 51 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 2 | 2018 | 84 | 0.050 |
Why?
|
| Tyrosine | 1 | 2004 | 93 | 0.050 |
Why?
|
| DNA, Neoplasm | 3 | 2013 | 61 | 0.050 |
Why?
|
| Karyotyping | 2 | 2017 | 48 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 27 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2004 | 127 | 0.050 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2003 | 13 | 0.050 |
Why?
|
| Mandible | 2 | 2013 | 8 | 0.050 |
Why?
|
| Cancellous Bone | 1 | 2022 | 4 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2022 | 18 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 544 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 576 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 49 | 0.050 |
Why?
|
| Doxycycline | 1 | 2022 | 47 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 57 | 0.050 |
Why?
|
| Ligands | 3 | 2010 | 415 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 60 | 0.050 |
Why?
|
| Hypotrichosis | 1 | 2002 | 4 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2003 | 167 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2002 | 30 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2001 | 1 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2002 | 58 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 130 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2012 | 116 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 130 | 0.040 |
Why?
|
| Spindle Apparatus | 1 | 2022 | 125 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 118 | 0.040 |
Why?
|
| Adipocytes | 2 | 2015 | 273 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 42 | 0.040 |
Why?
|
| Cell Compartmentation | 3 | 2007 | 34 | 0.040 |
Why?
|
| CpG Islands | 1 | 2002 | 219 | 0.040 |
Why?
|
| Acute Disease | 2 | 2017 | 663 | 0.040 |
Why?
|
| Gene Targeting | 2 | 2013 | 77 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2012 | 130 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 372 | 0.040 |
Why?
|
| Interleukin-3 | 2 | 2010 | 20 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2011 | 218 | 0.040 |
Why?
|
| Cell Count | 2 | 2011 | 128 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 66 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 22 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 16 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 1 | 2020 | 9 | 0.040 |
Why?
|
| Macromolecular Substances | 3 | 2006 | 162 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 22 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2020 | 90 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2010 | 193 | 0.040 |
Why?
|
| Methylene Chloride | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hexanes | 1 | 2019 | 3 | 0.040 |
Why?
|
| RNA Polymerase I | 2 | 2011 | 9 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2020 | 77 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2015 | 434 | 0.040 |
Why?
|
| Leptin | 1 | 2020 | 88 | 0.040 |
Why?
|
| E-Box Elements | 2 | 2009 | 5 | 0.040 |
Why?
|
| Intermediate Filaments | 2 | 2010 | 10 | 0.040 |
Why?
|
| Cattle | 2 | 2015 | 320 | 0.040 |
Why?
|
| Retinoid X Receptors | 3 | 2004 | 10 | 0.040 |
Why?
|
| 1-Butanol | 1 | 2018 | 2 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 603 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1698 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 182 | 0.040 |
Why?
|
| RNA Stability | 2 | 2011 | 104 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 2 | 2011 | 26 | 0.040 |
Why?
|
| Ovary | 2 | 2008 | 105 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2013 | 662 | 0.030 |
Why?
|
| Ring Chromosomes | 1 | 2017 | 3 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2017 | 13 | 0.030 |
Why?
|
| CHO Cells | 2 | 2010 | 192 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cytogenetic Analysis | 1 | 2017 | 26 | 0.030 |
Why?
|
| Mosaicism | 1 | 2017 | 29 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2008 | 6 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2017 | 5 | 0.030 |
Why?
|
| Heterozygote | 2 | 2009 | 173 | 0.030 |
Why?
|
| Cricetinae | 2 | 2010 | 362 | 0.030 |
Why?
|
| Jurkat Cells | 2 | 2010 | 109 | 0.030 |
Why?
|
| Body Weight | 2 | 2011 | 376 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 332 | 0.030 |
Why?
|
| A549 Cells | 1 | 2017 | 39 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 526 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 18 | 0.030 |
Why?
|
| Exons | 2 | 2010 | 205 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2017 | 13 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 2017 | 15 | 0.030 |
Why?
|
| Synoviocytes | 1 | 2016 | 1 | 0.030 |
Why?
|
| Serotonin Antagonists | 1 | 2017 | 31 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2017 | 84 | 0.030 |
Why?
|
| Mutagenesis | 2 | 2008 | 133 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2016 | 23 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2016 | 40 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2007 | 213 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 25 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2010 | 243 | 0.030 |
Why?
|
| Endoderm | 1 | 2016 | 47 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 83 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2015 | 17 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 37 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2016 | 66 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2017 | 148 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2015 | 50 | 0.030 |
Why?
|
| Chromosome Fragility | 1 | 2015 | 2 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 80 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 2008 | 105 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 96 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 128 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 261 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 113 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2015 | 13 | 0.030 |
Why?
|
| DNA Polymerase I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 869 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 29 | 0.030 |
Why?
|
| Annexin A5 | 2 | 2005 | 20 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 9 | 0.030 |
Why?
|
| Polyploidy | 1 | 2014 | 13 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cranial Fontanelles | 1 | 2014 | 1 | 0.030 |
Why?
|
| Genotype | 2 | 2009 | 673 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 20 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 64 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1141 | 0.030 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2013 | 5 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 147 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 361 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 113 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 328 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 414 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2013 | 32 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2013 | 13 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2013 | 27 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2013 | 104 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 86 | 0.020 |
Why?
|
| Genes, myc | 1 | 2013 | 18 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 46 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 624 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2002 | 129 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2012 | 1 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 241 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2008 | 1162 | 0.020 |
Why?
|
| Vitamin K Deficiency | 1 | 2012 | 3 | 0.020 |
Why?
|
| Dentin Dysplasia | 1 | 2012 | 1 | 0.020 |
Why?
|
| Odontoblasts | 1 | 2012 | 1 | 0.020 |
Why?
|
| Luciferases, Renilla | 1 | 2012 | 3 | 0.020 |
Why?
|
| Tooth | 1 | 2012 | 4 | 0.020 |
Why?
|
| Homozygote | 2 | 2002 | 122 | 0.020 |
Why?
|
| Ameloblasts | 1 | 2012 | 3 | 0.020 |
Why?
|
| Follistatin-Related Proteins | 1 | 2012 | 22 | 0.020 |
Why?
|
| Dental Enamel | 1 | 2012 | 13 | 0.020 |
Why?
|
| Joints | 1 | 2012 | 33 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 38 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2012 | 173 | 0.020 |
Why?
|
| Adolescent | 2 | 2017 | 6305 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2012 | 67 | 0.020 |
Why?
|
| Cellular Microenvironment | 1 | 2011 | 23 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 103 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 37 | 0.020 |
Why?
|
| SMARCB1 Protein | 1 | 2010 | 13 | 0.020 |
Why?
|
| Femur | 1 | 2011 | 55 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2010 | 14 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 31 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 44 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2010 | 31 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 139 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 57 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 563 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 80 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2010 | 17 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2010 | 21 | 0.020 |
Why?
|
| Leupeptins | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 103 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 52 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 23 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2004 | 699 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 116 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2010 | 30 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 287 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 32 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 12 | 0.020 |
Why?
|
| Protein Folding | 1 | 2011 | 268 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2009 | 1 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 108 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 43 | 0.020 |
Why?
|
| Freeze Drying | 1 | 2009 | 15 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 820 | 0.020 |
Why?
|
| Powders | 1 | 2009 | 21 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2009 | 18 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 181 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 133 | 0.020 |
Why?
|
| Progesterone | 1 | 2010 | 165 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 18 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2009 | 66 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2009 | 110 | 0.020 |
Why?
|
| Clavicle | 1 | 2008 | 3 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 235 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2009 | 42 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 116 | 0.020 |
Why?
|
| Lac Operon | 1 | 2008 | 26 | 0.020 |
Why?
|
| Sex Determination Processes | 1 | 2008 | 11 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2008 | 29 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2008 | 50 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 345 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2009 | 96 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2008 | 51 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2008 | 63 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 86 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2008 | 101 | 0.020 |
Why?
|
| Myogenin | 1 | 2008 | 16 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2008 | 76 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2008 | 45 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 56 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 364 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 72 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 180 | 0.020 |
Why?
|
| Biological Clocks | 1 | 2008 | 59 | 0.020 |
Why?
|
| Diatrizoate | 1 | 2007 | 4 | 0.020 |
Why?
|
| Ficoll | 1 | 2007 | 4 | 0.020 |
Why?
|
| Mimosine | 1 | 2007 | 1 | 0.020 |
Why?
|
| Coiled Bodies | 1 | 2007 | 4 | 0.020 |
Why?
|
| Aphidicolin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 293 | 0.020 |
Why?
|
| Nocodazole | 1 | 2007 | 14 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 39 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 160 | 0.020 |
Why?
|
| Muscles | 1 | 2008 | 179 | 0.020 |
Why?
|
| Water | 1 | 2009 | 314 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2007 | 9 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 81 | 0.020 |
Why?
|
| E2F4 Transcription Factor | 1 | 2007 | 2 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 298 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 98 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 12 | 0.020 |
Why?
|
| Purines | 1 | 2007 | 43 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2007 | 90 | 0.020 |
Why?
|
| Chromatids | 1 | 2007 | 15 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 185 | 0.020 |
Why?
|
| Hippocampus | 1 | 2008 | 276 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 87 | 0.020 |
Why?
|
| Lymphoma | 1 | 2007 | 101 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 391 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2006 | 15 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2005 | 41 | 0.010 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 7 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 624 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 2374 | 0.010 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 62 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 144 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2006 | 201 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2006 | 102 | 0.010 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2005 | 8 | 0.010 |
Why?
|
| Collagenases | 1 | 2005 | 16 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 321 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 190 | 0.010 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2004 | 3 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 447 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 70 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5612 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 2004 | 8 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2004 | 28 | 0.010 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 12 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2004 | 18 | 0.010 |
Why?
|
| Chloroform | 1 | 2003 | 4 | 0.010 |
Why?
|
| Acetic Acid | 1 | 2003 | 10 | 0.010 |
Why?
|
| Telophase | 1 | 2003 | 5 | 0.010 |
Why?
|
| Fixatives | 1 | 2003 | 16 | 0.010 |
Why?
|
| Methanol | 1 | 2003 | 10 | 0.010 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2003 | 14 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 40 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2003 | 33 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2004 | 64 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 102 | 0.010 |
Why?
|
| Dissection | 1 | 2003 | 46 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2003 | 20 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 202 | 0.010 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2003 | 2 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 34 | 0.010 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2003 | 12 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 61 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 140 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 180 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 187 | 0.010 |
Why?
|
| Core Binding Factors | 1 | 2002 | 1 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 491 | 0.010 |
Why?
|
| Histone Deacetylase 6 | 1 | 2002 | 8 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 67 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 339 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2003 | 316 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 102 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 662 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 176 | 0.010 |
Why?
|
| Digestive System | 1 | 2002 | 26 | 0.010 |
Why?
|
| Dermis | 1 | 2002 | 22 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2001 | 22 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 23 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 384 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 21 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 145 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 52 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2002 | 94 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 178 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 281 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 453 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2001 | 103 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 272 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 2003 | 227 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 367 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 952 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 875 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 449 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14958 | 0.010 |
Why?
|
| Liver | 1 | 2002 | 871 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 18267 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 5788 | 0.010 |
Why?
|
| Child | 1 | 2006 | 4612 | 0.010 |
Why?
|